Abstract
Our study addresses the growing concern posed by Klebsiella pneumoniae, a significant pathogen acknowledged by the World Health Organization (WHO). This bacterium is particularly alarming due to its association with antimicrobial resistance (AMR), impacting immunologically vulnerable populations, especially in hospital settings, and playing a crucial role in wound management. Moreover, this pathogen raises significant concerns in maternal and child health, being correlated with adverse outcomes like pre-term birth, low birth weight, and increased susceptibility to infections in new-borns, often resulting in morbidity and mortality.
A major obstacle to the effective and timely management of K. pneumoniae infections is the absence of rapid and cost-effective detection tools in resource-poor point-of-care (POC) settings. This study introduces an innovative combination of three POC-compatible methods: Insta DNA™ card-based sample collection and DNA extraction, Recombinase polymerase amplification (RPA)-based isothermal amplification, and a silver nanoparticle (AgNP) aggregation assay for visual detection. Together, these methods offer simple yet highly sensitive, specific, and rapid visual detection of as few as ∼1 bacterium of K. pneumoniae within ∼45 minutes. The synergy of these methods eliminates the need for sophisticated equipment, making it highly suitable for field and resource-poor POC applications.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
RJD is thankful to Birla Institute of Science and Technology (BITS) Pilani, Hyderabad campus, India for their funding support through intramural funding under Research Initiation Grant (RIG) and Centre for Human Disease Research (CHDR). RJD is thankful to Defence Research and Development Organization (DRDO), India for supporting through research grant (LSRB/81/48222/LSRB-367/BTB/2020). RJD is thankful to the overall infrastructure support by Department of Biological Sciences, BITS Pilani Hyderabad. NP is thankful to Indian Council of Medical Research (ICMR), Govt. of India for providing Senior Research Fellowship (RBMH/FW/2019/13). NO is thankful to LSRB, DRDO and BITS Pilani Hyderabad for fellowship.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability statement
All data that supports the findings of this study are available from corresponding author upon reasonable request.
Abbreviations
- M. tb
- Mycobacterium tuberculosis
- M. bovis
- Mycobacterium bovis
- POC
- Point-of-care
- ml
- Millilitre
- µl
- microlitre
- PCR
- Polymerase Chain Reaction
- DNA
- Deoxyribonucleic acid
- qPCR
- Quantitative PCR
- NTC
- no-template-control
- NaAc
- Sodium Acetate
- AgNP
- Silver Nanoparticles
- dsDNA
- Double stranded DNA
- Tris
- Tris(hydroxymethyl)aminomethane
- EDTA
- Ethylene diamine tetra-acetic acid
- NaCl
- Sodium Chloride
- LAMP
- Loop-mediated Isothermal Amplification
- RPA
- Recombinase Polymerase Amplification
- MCDA
- Multiple cross displacement amplification
- BCG
- Bacille Calmette-Geurin
- WHO
- World Health Organisation.
